计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| P126920-1mg |
1mg |
现货 ![]() |
| |
| P126920-5mg |
5mg |
现货 ![]() |
| |
| P126920-10mg |
10mg |
现货 ![]() |
| |
| P126920-25mg |
25mg |
现货 ![]() |
| |
| P126920-50mg |
50mg |
现货 ![]() |
| |
| P126920-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | NCGC00238454-02 | NCGC00238454-10 | PIK 90 | N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)nicotinamide | PI 3-K inhibitor IX | Q27167207 | SB19249 | N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyridine-3-carboxamide | AKOS015969 |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | PIK-90 |
| 生化机理 | PIK-90 是一种 PI3K 抑制剂,对 p110 α、β、γ 和 δ 同工酶的 IC50=11、350、18 和 58。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
PIK-90是一种广谱的PI3K抑制剂,对p110α、p110β、p110γ和p110δ的IC50值分别为11 nM、350 nM、18 nM和58 nM。
研究表明,PIK-90在1 μmol/L时可诱导IgE分泌水平增加,但在2 μmol/L以上剂量时则可抑制IgE生成[2]。PIk-90可阻断Akt磷酸化。在LN229 PTENWT细胞中,PIK-90与CDK2抑制剂联合使用可诱发细胞凋亡。此外,PIK-90与CDK1和CDK2的siRNA联合使用可诱发细胞死亡,但是PIK-90与CDK1或CDK2的siRNA联合使用则无细胞凋亡效果。
在植入GBM43细胞的裸鼠中,PIK-90与roscovitine联合使用可显著减少肿瘤大小。
PIK-90是一种PI3Kα/γ/δ抑制剂,IC50分别为11 nM/18 nM/58 nM,对PI3Kβ作用效果稍弱。 A cell-permeable imidazoquinazoline compound that acts as a potent, reversible, and ATP-competitive inhibitor against all three classes of PI 3-K kinases (IC50 = 11, 18, 47, 58, 64, 350, and 830 nM against p110α, p110γ, PI 3-KC2α, p110δ, PI 3-KC2β, p110β, and hsVPS34, respectively), as well as several PIKKs (IC50 = 13, 610, and 1050 nM against DNA-PK, ATM, and mTORC1, respectively) and PI 4-KIIIα (IC50 = 830 nM), while exhibiting much reduced potency against PI 4-KIIIβ and ATR (IC50 = 3.1 and 15 µM, respectively) and little or no activity toward PI 4-KIIα, PIPKs (IC50 >100 µM), and a panel of 36 commonly studied protein kinases (<15% inhibition at 10 µM). Effectively suppreses insulin-stimulated phosphorylations of Akt and rpS6 in 3T3-L1 adipocytes and L6 myotubes in a dose-dependent manner in vitro (by >90% at 2.5 µM) and completely prevents insulin-induced blood glucose decline in mice in vivo (10 mg/ml, i.p.). |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488202817 |
|---|---|
| 分子类型 | 小分子 |
| IUPAC Name | N-(7,8-dimethoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene)pyridine-3-carboxamide |
| INCHI | InChI=1S/C18H17N5O3/c1-25-13-6-5-12-14(15(13)26-2)21-18(23-9-8-20-16(12)23)22-17(24)11-4-3-7-19-10-11/h3-7,10,20H,8-9H2,1-2H3 |
| InChi Key | FCKJZIRDZMVDEM-UHFFFAOYSA-N |
| Canonical SMILES | COC1=C(C2=NC(=NC(=O)C3=CN=CC=C3)N4CCNC4=C2C=C1)OC |
| Isomeric SMILES | COC1=C(C2=NC(=NC(=O)C3=CN=CC=C3)N4CCNC4=C2C=C1)OC |
| PubChem CID | 135398491 |
| 分子量 | 351.36 |
| 溶解性 | DMSO 0.28 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
|---|---|
| 敏感性 | 对光线敏感 |
| 分子量 | 351.400 g/mol |
| XLogP3 | 1.300 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 351.133 Da |
| 单同位素质量Monoisotopic Mass | 351.133 Da |
| 拓扑极表面积Topological Polar Surface Area | 88.400 Ų |
| 重原子数Heavy Atom Count | 26 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 778.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| Purity(HPLC) | 98-100(%) |
|---|---|
| Appearance(P126920) | White or off-white or light-yellow solid |
| NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-18 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 24-12-10 | P126920 | |
| 分析证书 | 22-09-14 | P126920 |